Cargando…

Current Knowledge on Factor V Leiden Mutation as a Risk Factor for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis

BACKGROUND: Thrombophilia screening is widely done in clinical practice, and it is claimed that the extent of venous thromboembolism (VTE) recurrence risk in patients with common defects is still not fully understood. AIM: We aimed to summarize data of all observational studies prospectively assessi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eppenberger, Daria, Nilius, Henning, Anagnostelis, Betsy, Huber, Carola A., Nagler, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021545/ https://www.ncbi.nlm.nih.gov/pubmed/35463779 http://dx.doi.org/10.3389/fcvm.2022.883986

Ejemplares similares

Secondary prevention of venous thromboembolism: Predictors and outcomes of guideline adherence in a long-term prospective cohort study
por: Mertins, Tamara, et al.
Publicado: (2022)

Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study
por: Nilius, Henning, et al.
Publicado: (2021)

Association of venous thromboembolism and myocardial infarction with Factor V Leiden and Factor II gene mutations among Libyan patients
por: Msalati, Abdulghani, et al.
Publicado: (2021)

A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism
por: Takhviji, Vahideh, et al.
Publicado: (2021)

Risk of venous thromboembolism in association with factor V leiden in cancer patients – The EDITH case-control study
por: Heraudeau, Adeline, et al.
Publicado: (2018)

Factor V Leiden, estrogen, and multimorbidity association with venous thromboembolism in a British-South Asian cohort
por: Magavern, Emma F., et al.
Publicado: (2023)

The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
por: Machado, Marcia, et al.
Publicado: (2023)

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
por: Nopp, Stephan, et al.
Publicado: (2022)

Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
por: Nagler, Michael, et al.
Publicado: (2021)

Systematic Review and Meta-Analysis of the Susceptibility of ABO Blood Groups to Venous Thromboembolism in Individuals with Factor V Leiden
por: Bawazir, Waleed M.
Publicado: (2022)

Factor XI, a potential target for anticoagulation therapy for venous thromboembolism
por: Li, Tingting, et al.
Publicado: (2022)

Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study
por: Nguyen, Cu Dinh, et al.
Publicado: (2013)

Editorial: Venous thromboembolism and pregnancy
por: Tardy, Bernard, et al.
Publicado: (2022)

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

Venous Thromboembolism Risk Score and Pregnancy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

Editorial: COVID-19 and Venous Thromboembolism
por: Yamashita, Yugo
Publicado: (2021)

Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients
por: Kreidy, Raghid
Publicado: (2012)

Severe hyperhomocysteinemia due to cystathionine β-synthase deficiency, and Factor V Leiden mutation in a patient with recurrent venous thrombosis
por: Awan, Zuhier, et al.
Publicado: (2014)

Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea: A case report
por: Choe, Hun Jee, et al.
Publicado: (2019)

Recurrent pregnancy loss: can factor V Leiden mutations be a cause
por: Reddy, R R N, et al.
Publicado: (2019)

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism
por: Nemeth, Banne, et al.
Publicado: (2019)

Preeclampsia and Venous Thromboembolism: Pathophysiology and Potential Therapy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident
por: Ali, Nadir, et al.
Publicado: (2014)

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension
por: Zhu, Yong-Jian, et al.
Publicado: (2021)

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

The Cumulative Incidence and Risk Factors of Recurrent Venous Thromboembolism in the Elderly
por: Aleidan, Fahad A S
Publicado: (2020)

Clinical epidemiology of venous thromboembolic disease: An institutional registry
por: AlSheef, Mohammed, et al.
Publicado: (2022)

ExPeKT—Exploring prevention and knowledge of venous thromboembolism: a two-stage, mixed-method study protocol
por: McFarland, Lorraine, et al.
Publicado: (2013)

Missense mutation of SERPINC1 (p.Ser426Leu) in a young patient presenting as refractory and recurrent venous thromboembolism: A case report
por: Yu, Haixu, et al.
Publicado: (2022)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

HELLP Syndrome and Cerebral Venous Sinus Thrombosis Associated with Factor V Leiden Mutation during Pregnancy
por: Dag, Zeynep Ozcan, et al.
Publicado: (2014)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review
por: Blondon, Marc, et al.
Publicado: (2022)

Protein S Deficiency and the Risk of Venous Thromboembolism in the Han Chinese Population
por: Wu, Yingying, et al.
Publicado: (2022)

Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis
por: Yusuf, Mohd, et al.
Publicado: (2012)

Incidence and Risk Factors of Recurrent Venous Thromboembolism after Pulmonary Embolism
por: Hwang, Hun-Gyu, et al.
Publicado: (2019)

Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants
por: Qureshi, Waqas, et al.
Publicado: (2016)

Patient Characteristics and Preferences Regarding Anticoagulant Treatment in Venous Thromboembolic Disease
por: Lanéelle, Damien, et al.
Publicado: (2021)

Predictors of pregnancy-associated venous thromboembolism: A case-control study
por: Alsheef, Mohammed A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_viverd3ic1r1495cmjtkdmaffi